Prisma Health would like to make sure that you have the information you need to stay informed about the COVID-19 vaccine.
Note: You MUST have an appointment through the CDC’s Vaccine Administration Management System (VAMS) with a QR code to be vaccinated at one of our sites.
Phase 1a and individuals age 70+ are eligible for the COVID-19 vaccine
Prisma Health is working rapidly to provide the COVID-19 vaccine to phase 1a individuals and SC residents age 70+. If you are eligible, fill out a form to request the vaccine.
This is the process to request a vaccine:
• Fill out our vaccine request form or call us at 833-2PRISMA (833-277-4762). Note that each person must have their own email. You can not register more than one person with the same email.
• You will receive an email from Marketing@PrismaHealth.org to confirm receipt of your online request form. This is not an appointment.
• You will receive an email from the CDC with a link to the Vaccine Administration Management System (VAMS). This link is unique to you and cannot be shared with anyone else.
• Click the link to the VAMS portal and create a username and password. Do not use Internet Explorer. Use Google Chrome, Safari or other web browser.
• Follow the instructions, which include completing a medical questionnaire and scheduling an appointment.
Vaccine Request Please note the following:
• Be patient. We are working hard on all the details in an environment that is changing rapidly. There may be a delay before you receive an email from the CDC to register and schedule your appointment using their VAMS portal.
• Do not submit multiple vaccine request forms or leave multiple messages on the phone line.
• Do not call individual physician practices, Prisma Health pharmacies or hospitals about vaccines.
• Appointments will be based on the limited supply of vaccine available.
• Walk-ins are not accepted. You must register and schedule an appointment in the CDC’s VAMS portal.
Vaccine distribution at Prisma Health
As of Jan. 14, Prisma Health has administered 27,315 vaccinations (23,924 first doses and 3,391 second doses). Of those, there have been only 3 moderate reactions and 0 severe reactions. Phase 1a community members are included in this number in addition to team members.■
